Literature DB >> 12848601

[Superior vena cava syndrome and insular thyroid carcinoma: the stent as a palliative therapeutic alternative].

M Lorenzo-Solar1, J Lado-Abeal, J Cameselle-Teijeiro, M García Vázquez, J Cabezas-Cerrato.   

Abstract

The superior vena cava syndrome (SVCS) is a uncommon complication of thyroid cancers. It is produced as consequence of the mediastinal spread of the tumor or by intravascular invasion with thrombosis. We describe a case of insular thyroid carcinoma with an SVCS solved by putting an intravenous stent. The patient was a 73 year old male that consulted for aphonia and presence of a tumor in the right side of the neck of two months of evolution. The PAAF of thyroid suggested the diagnosis of "follicular tumor". A total thyroidectomy was performed on the patient and the sample histological study revealed the existence of a insular carcinoma. An ablative dosis of 131I was administered to him. One year after the patient developed the SVCS. A TAC detected a tumoral relapse consistent with clinical syntoms, and was confirmed by a high level of Tg (with TgAntibodies -). As the patient showed a slight response to radiotherapy (52Gy), a thoracic phlebography was realized demostrating an extense upper vena cava obstruction. After having accomplished an angioplasty, a long stent (20 mm wide) was put into the upper vena cava that was followed by a fast clinical and radiological improvement. A new phlebography practiced three month later showed a rapid venous flux through the stent, and near total disapperance of collateral circulation on thorax wall and mediastinum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12848601

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  1 in total

1.  Thyroid cancer causing obstruction of the great veins in the neck.

Authors:  Steve L Hyer; Prasad Dandekar; Kate Newbold; Masud Haq; Kshama Wechalakar; Khin Thway; Clive Harmer
Journal:  World J Surg Oncol       Date:  2008-04-03       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.